New clinical trial – capsaicin nanoparticles in patients with painful diabetic neuropathy

Mahidol University and the Thailand Research Fund recently started a phase II/III clinical trial involving a capsaicin nanoparticle preparation, now registered in the database under reference NCT01125215. According to this page, the aim is to “determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy“. The study is currently recruiting participants.


One Response

  1. Nanotechnology has many opportunities. It could give a very important role in health sector.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: